Lance R. McMahon, Ph.D.

Pharmacology University of Texas Health Science Center - San Antonio 
Behavioral pharmacology
"Lance McMahon"
Mean distance: 16.5 (cluster 19)
Cross-listing: Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Obeng S, Hiranita T, León F, et al. (2021) Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. Journal of Medicinal Chemistry
Wilkerson JL, Felix JS, Bilbrey JA, et al. (2021) Characterization of a mouse neuropathic pain model caused by the highly active antiviral therapy (HAART) Stavudine. Pharmacological Reports : Pr
Chear NJ, León F, Sharma A, et al. (2021) Exploring the Chemistry of Alkaloids from Malaysian (Kratom) and the Role of Oxindoles on Human Opioid Receptors. Journal of Natural Products
Obeng S, Wilkerson JL, León F, et al. (2020) Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for Mu-Opioid Receptor and Opioid-Like Behavioral Effects in Rats. The Journal of Pharmacology and Experimental Therapeutics
Behnood-Rod A, Chellian R, Wilson R, et al. (2020) Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats. Drug and Alcohol Dependence. 215: 108235
Corrie LW, Stokes C, Wilkerson JL, et al. (2020) Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives. Molecular Pharmacology
Wilkerson JL, Jiang J, Felix JS, et al. (2020) Alterations in mouse spinal cord and sciatic nerve microRNAs after the chronic constriction injury (CCI) model of neuropathic pain. Neuroscience Letters. 135029
de Moura FB, Hiranita T, McMahon LR. (2020) The discriminative stimulus effects of epibatidine in C57BL/6J mice. Behavioural Pharmacology
Moerke MJ, McMahon LR, Wilkerson JL. (2020) More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder. Pharmacological Reviews. 72: 527-557
Wilkerson JL, Deba F, Crowley ML, et al. (2020) Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators. Neuropharmacology. 168: 108008
See more...